![]() |
Company: Astellas Pharma in association with Wizzard Communications Campaign: Empowering patients with overactive bladder |
Criteria
This Award highlights the increasing importance of the patient within today’s healthcare marketing. It relates to European, national or local projects undertaken in 2009 that demonstrated having made a significant and measurable difference to a specific group of patients.
Judges were looking for proof that entrants had identified how their campaign directly contributed to, for example, increasing the level of patient compliance, or modified the perception or behaviour of patients leading to improved diagnosis and treatment (taking into consideration the regulatory bounds and codes of practice.)
Campaign overviewDuring 2009, Astellas made very real progress towards making a difference to undiagnosed patients with the symptoms of overactive bladder. Added impact and credibility came from running the campaign in partnership with the Bladder and Bowel Foundation. By retaining a single minded focus on three strategic imperatives, the team delivered a series of innovative, memorable and highly effective initiatives resulting in improved diagnosis and treatment of this highly debilitating condition. |
![]() |
"This exciting and high-impact campaign really delivered. It showed highly effective collaboration with patient organisations, changed perceptions, reversed a declining market trend, increased sales and improved patient outcomes so generating positive outcomes for all stakeholders."
"This campaign clearly demonstrates that focusing on patients in the right way will deliver great results."
Other entries
Entry deadline | 27 August 2020 |
Extended entry deadline | 3 September 2020* *additional fee applies |
Judging Day | 1 October 2020 |
Company of the Year Interviews | 22 October 2020 |
PMEA Event | 25 November 2020 |